Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mandar S. Deshpande is active.

Publication


Featured researches published by Mandar S. Deshpande.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2009

Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: Need for a randomized controlled trial

Anil D'Cruz; Ravichand C. Siddachari; Rohan R. Walvekar; Gouri Pantvaidya; Devendra Chaukar; Mandar S. Deshpande; Prathamesh Pai; Pankaj Chaturvedi

The aim of this study is to determine the need for a randomized controlled trial in order to define the role of an elective neck dissection (END) in the treatment of early tongue cancers.


Oral Oncology | 2009

Verrucous carcinoma of the oral cavity: A clinical and pathological study of 101 cases

Rohan R. Walvekar; Devendra Chaukar; Mandar S. Deshpande; Prathamesh Pai; Pankaj Chaturvedi; Anagha Kakade; S. Kane; Anil D’Cruz

This paper studies the clinical and pathological predictors of local recurrence and disease-free survival (DFS) in patients with oral verrucous carcinoma (OVC) treated surgically, through a retrospective chart review. Three hundred and two patients with OVC were identified from January 1990 to December 2000, of which, 101 surgically treated patients who fulfilled our inclusion criteria were analyzed. A univariate analysis (UVA) of important prognostic factors, patterns of recurrence, and DFS is reported. Seventy-nine patients were male (M:F ratio, 3.6:1) and the mean age at presentation was 53.9 years (range, 23-90 years). The median follow up was 4.61 years (range, 0.51-14.3 years). The incidence of tobacco chewing, smoking, and alcohol intake was 77%, 42%, and 10%, respectively. Thirty-four patients (33.7%) had either leukoplakia or submucous fibrosis (SMF) on oral cavity examination. Early-stage tumors accounted for 39.7%; while 60.4% were late-stage tumors. On UVA, tumor location, presence of a premalignant lesion, smoking, and positive margins were statistically significant. Sixty-eight percent (19/28) recurred locally. The salvage rate for recurrent tumors was 66.7% (16/28) with a median post-recurrence survival of 16 months (range, 10-83 months). The five year DFS with surgical therapy was 77.6%. OVC has an excellent prognosis with surgical treatment. The significance of positive margins emphasizes the need for adequate surgical resection. Additionally, the presence of either leukoplakia or SMF and tumor location in the upper alveolar-palatal complex is associated with worse outcomes. Neck dissection, if considered, may be limited to a supra-omohyoid neck dissection (SOHND).


Journal of Cancer Research and Therapeutics | 2005

A prospective study of pharyngocutaneous fistulas following total laryngectomy

Sajid S. Qureshi; Pankaj Chaturvedi; P. Pai; Devendra Chaukar; Mandar S. Deshpande; Kumar Alok Pathak

Pharyngocutaneous (PC) fistula is a common complication following laryngectomy. It leads to increased morbidity, delay in adjuvant treatment, prolonged hospitalization and an increase in treatment costs. Although a number of factors that result in PC fistula have been described, there is still no agreement on the most significant factors. We undertook a prospective study to critically analyze PC fistula and its association with various tumors, patient and treatment related factors. This was a prospective study that included 143 patients who underwent laryngeal surgery for squamous cell carcinoma of the larynx and pyriform sinus. Use of pectoralis major myocutaneous flap to reconstruct the neopharynx, primary disease in pyriform and extensive soft tissue infiltration were significantly associated with PC fistula. Prior treatment (radiotherapy and chemotherapy), type of closure (T closure, Y closure and vertical closure), Layers of closure (full thickness interrupted, submucosal interrupted, submucosal continuous) type of suture material (silk, vicryl ), age, sex, stage, preoperative tracheostomy, cut margin status, pre/postoperative hemoglobin and experience of surgeons did not relate significantly.


The Annals of Thoracic Surgery | 2002

Small cell carcinoma of the esophagus: the Tata Memorial Hospital experience

Gouri Pantvaidya; C.S. Pramesh; Mandar S. Deshpande; Nirmala A. Jambhekar; Sanjay Sharma; Ramakant K. Deshpande

BACKGROUND Small cell carcinoma of the esophagus is a rare disease, characterized by aggressive progression. It has a high incidence of metastatic disease at presentation and a poor overall prognosis. Treatment protocols are not well established because of the paucity of cases and a lack of large studies. METHODS We performed a retrospective review of all patients with small cell carcinoma of the esophagus diagnosed at the Tata Memorial Hospital between 1985 and 2001. We retrieved and analyzed data regarding demographic details, diagnosis, staging, type of treatment, and overall survival. RESULTS Eighteen patients with a mean age of 62 years (range 48 to 80 years) diagnosed as having small cell carcinoma of the esophagus were analyzed. The group included 13 men and 5 women. Seven of the 18 patients (39%) presented with metastatic disease including 5 patients (28%) with liver metastases. Four patients were treated with surgery, with or without chemotherapy or radiotherapy. Three patients were treated with combination chemoradiotherapy, 2 patients with chemotherapy alone, and 5 patients with radiotherapy alone. Four patients with advanced disease and poor general condition were not offered any treatment. The overall median survival of our patients was 6 months. Patients treated with surgery and chemotherapy had a better overall survival. CONCLUSIONS Small cell carcinoma of the esophagus should be regarded as a systemic disease with a high distant failure rate. Treatment strategies hence must incorporate systemic chemotherapy along with radical surgery or radiotherapy as part of a multimodality approach.


American Journal of Otolaryngology | 2009

Quality of life in head and neck cancer survivors: a cross-sectional survey

Devendra Chaukar; Rohan R. Walvekar; Ashok Kumar Das; Mandar S. Deshpande; Prathamesh Pai; Pankaj Chaturvedi; Anagha Kakade; Anil D'Cruz

PURPOSE Head and neck cancer (HNC) survivors have substantial psychological distress in addition to treatment-related side effects. This study examines the long-term quality of life (QOL) of HNC survivors in a busy tertiary care center. MATERIAL AND METHODS A prospective, cross-sectional survey was conducted studying 212 HNC survivors 1 year after completion of their treatment at a tertiary cancer center. Quality of life assessments were performed using the 2 standardized health-related QOL questionnaires: The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 and The Quality of Life Questionnaire Head and Neck Cancer Module. RESULTS The overall global QOL rating for the study cohort was satisfactory. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 scores showed that the domains where most patients faired poorly included financial difficulties (54%), appetite loss (36%), fatigue (33%), and cough (30%). The Quality of Life Questionnaire Head and Neck Cancer Module scale identified the domains with poor scores to be dry mouth (64%), dental problems (42%), sticky saliva (40%), cough (39%), and problems with mouth opening (32%). Patients with early-stage tumors and those treated with surgery alone had significantly better QOL scores when compared with advanced stage tumors and patients receiving either radiation alone or multimodality treatment, respectively. CONCLUSIONS Quality of life questionnaires provide a medium for patients to effectively communicate with their physician in a busy tertiary care facility and provide an insight into the physical, psychological, and social problems affecting our patients which can then direct future interventions.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2005

ADVANCED SQUAMOUS CELL CARCINOMA OF LOWER GINGIVOBUCCAL COMPLEX: PATTERNS OF SPREAD AND FAILURE

Kumar Alok Pathak; Samir Gupta; Sanjay Talole; Vishal Khanna; Pankaj Chaturvedi; Mandar S. Deshpande; Prathamesh Pai; Devendra Chaukar; Anil D'Cruz

Carcinoma of the gingivobuccal complex is commonly associated with the use of smokeless tobacco known as “quid.”


Oral Oncology | 2009

Squamous cell carcinoma of the gingivobuccal complex: Predictors of locoregional failure in stage III–IV cancers

Rohan R. Walvekar; Devendra Chaukar; Mandar S. Deshpande; Prathamesh Pai; Pankaj Chaturvedi; Anagha Kakade; Anil D’Cruz

The purpose of our study was to analyze the indicators of loco-regional failure in a large cohort of patients with gingivobuccal complex tumors treated at a single institution. A retrospective review of 2275 patients diagnosed with tumors of the gingivobuccal complex was conducted from January 1997 to December 1999; 642 patients who fulfilled our inclusion criteria were analyzed. A univariate analysis, multivariate analysis, and disease-free survival are reported. During a median follow up of 2.51 years, there were 228 (35.5%) recurrences with a median post-recurrence survival of 2.7 months. The incidence of occult neck metastasis was 29%. The 2- and 5-year DFS rates were 63.8% and 53.3%, respectively. On multivariate analysis, tumor depth and metastatic lymphadenopathy were found to be independent prognostic factors for disease-free survival. Advanced gingivobuccal cancers fail loco-regionally. Cervical metastasis and tumor depth influence disease-free survival. Elective neck dissection due to a high incidence of occult neck disease is recommended.


International Journal of Oral and Maxillofacial Surgery | 2009

Cancer of the buccal mucosa: a tale of two continents☆

Kumar Alok Pathak; R. Nason; Sanjay Talole; A. Abdoh; P. Pai; Mandar S. Deshpande; Pankaj Chaturvedi; Devendra Chaukar; Anil D’Cruz; R. Bhalavat

Squamous cell carcinoma (SCC) of the buccal mucosa in North America is thought to be different from that in the Indian subcontinent. This study compared the treatment outcomes and prognostic factors in 64 patients with SCC of the buccal mucosa treated at Cancer Care Manitoba (CCMB), Canada, and 64 similar patients treated at the Tata Memorial Hospital (TMH), India. Overall, cause-specific and disease-free survival for the two geographical groups were calculated and the impact of individual prognostic factors on survival was assessed. CCMB patients were significantly older (p<0.001), had less differentiated tumour (p=0.053) and had higher chances of positive or close surgical margins (p=0.012). At 5 years, they had lower 5-year overall survival (57.4% versus 80.1%; p<0.001), cancer-specific survival (76.4% versus 85.0%; p=0.043) and disease-free survival (42.9% versus 66.4%; p=0.004). Age had an independent influence on overall survival and cause-specific survival. After adjusting for age there was no difference in cause-specific survival between the two groups (HR=1.20; 95% CI=0.46,3.17; p=0.710). The apparent survival difference between the CCMB and TMH patients was due to the difference in the age of presentation and not because of different biological behaviour.


Journal of Cancer Research and Therapeutics | 2007

Malignant pilar tumor of the scalp: A case report and review of literature

Manish Siddha; Ashwini Budrukkar; Tanuja Shet; Mandar S. Deshpande; Ayan Basu; Nikhilesh Patil; Rajendra L. Bhalavat

Pilar tumor is a rare neoplasm arising from the external root sheath of the hair follicle and is most commonly observed on the scalp. These tumors are largely benign, often cystic, and are characterized by trichilemmal keratinization. Wide local excision has been the standard treatment. Recent reports have described a rare malignant variant with an aggressive clinical course and a propensity for nodal and distant metastases which, therefore, merits aggressive treatment. In this report, we present a case of malignant pilar tumor of the scalp with multiple nodal metastases at presentation. Diagnostic and therapeutic considerations, in the form of adjuvant radiotherapy, are subsequently discussed.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2009

VALIDATION AND ASSESSMENT OF VOICE-RELATED QUALITY OF LIFE IN INDIAN PATIENTS UNDERGOING TOTAL LARYNGECTOMY AND PRIMARY TRACHEOESOPHAGEAL PUNCTURE

Mandar S. Deshpande; Anagha Kakade; Devendra Chaukar; Vinod T. Gore; Prathamesh Pai; Pankaj Chaturvedi; Anil D'Cruz

Voice‐related quality of life (V‐RQOL) has never been studied in Indian patients. This study was planned to validate and assess V‐RQOL in patients using tracheoesophageal puncture (TEP).

Collaboration


Dive into the Mandar S. Deshpande's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anil D'Cruz

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P. Pai

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge